Learn about this vaccine that protects against a common seasonal virus that can sometimes cause severe disease, with info on ...

A new Centers for Disease Control and Prevention (CDC) report reveals low uptake of flu, COVID-19 and respiratory syncytial ...

COVID-19, influenza, and respiratory syncytial virus vaccination coverage is low among adults so far this respiratory virus season (2024 to 2025).

COVID-19, influenza, and respiratory syncytial virus (RSV) vaccination coverage is low among nursing home residents e ...

GSK (GSK.L), opens new tab said on Friday that its respiratory syncytial virus (RSV) vaccine has received approval in Japan for expanded use in adults aged between 50 and 59, who are at increased ...

with an increased risk for severe RSV had ever received an RSV vaccine. There was variation seen in coverage by jurisdiction and demographic characteristics, with younger adults and those without ...

Vaccines against both viruses, however, have been difficult to design. Now, scientists have analyzed the structure and stability of a critical RSV and hMPV protein to better design vaccines that ...

Respiratory syncytial virus (RSV) vaccine timing can influence how effectively antibodies are transferred to newborns. Earlier vaccination ensures maximum protection for tiny lungs! # ...

RSV vaccination at least five weeks prior to delivery results in the highest transplacental transfer of maternal antibodies to the neonate.

"This could alleviate the overall health burden during flu season, which is also when most RSV and hMPV cases occur." Scientists have long attempted to create vaccines that coax the immune system ...